Der wesentliche Fortschritt in der Behandlung von Menschen mit einem Typ-1-Diabetes
besteht in der stetigen Weiterentwicklung der technischen Möglichkeiten. Insbesondere
im Kindes- und Jugendalter ist die Verwendung von Insulinpumpen und Glukosesensoren
sehr beliebt. Durch die Kombination beider Systeme ist mittlerweile eine (teil-)automatische
Insulindosierung (AID) realisiert. Sie bietet entscheidende Vorteile, um die Stoffwechselziele
zu erreichen.
Abstract
In pediatric diabetology, insulin pumps and glucose sensors represent the standard
course of therapy in Germany. By combining both systems, hybrid automatic insulin
dosing (AID) can be realized. The first systems can be prescribed at the expense of
the statutory health insurance. They offer people with diabetes decisive advantages
in achieving metabolic targets, but are not yet approved for all age groups. For the
evaluation of individual metabolic adjustment and counseling, the “time in range”
has become an established parameter. Structured age- and situation-appropriate training
is essential for a sustainable, successful use of the systems. The rapid increase
in commercially available AID systems poses great challenges to diabetes teams. Since
a lot of detailed knowledge of the functioning of the various systems is required
for proper counseling, training and care, structures for quality-assured diabetological
care in this rapidly developing field must be
established as soon as possible using the opportunities of telemedicine.
Schlüsselwörter
Typ-1-Diabetes - Insulinpumpe - Glukosesensor - Automatische Insulindosierung
Keywords
Type 1 diabetes - insulin pump - glucose sensor - automated insulin delivery
